CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.000
+0.080 (4.17%)
Nov 14, 2025, 4:00 PM EST - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $23.08 million as of November 14, 2025. Its market cap has decreased by -21.88% in one year.
Market Cap
23.08M
Enterprise Value
20.76M
1-Year Change
-21.88%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $23.08M, a decrease of -49.95%. That is a compound annual growth rate of -23.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 22.16M | -43.53% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 921.79B |
| Johnson & Johnson | 473.81B |
| AbbVie | 413.62B |
| UnitedHealth Group | 291.31B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 232.96B |
| Abbott Laboratories | 226.54B |